Pancreatic cancer: New hopes after first line treatment

doi:10.4251/wjgo.v8.i9.682

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7067)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

539

WORD

393

HTML

3529

Figures (1-1)

165

Tables (1-2)

165

Sum=4791

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1046

Download

1230

Sum=2276

Sep 15, 2016 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (19)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Oncol. Sep 15, 2016; 8(9): 682-687
Published online Sep 15, 2016. doi: 10.4251/wjgo.v8.i9.682

Pancreatic cancer: New hopes after first line treatment

Francesca Aroldi, Paola Bertocchi, Giordano Savelli, Edoardo Rosso, Alberto Zaniboni

Francesca Aroldi, Paola Bertocchi, Alberto Zaniboni, Department of Medical Oncology, Poliambulanza Foundation, 25124 Brescia, Italy

Giordano Savelli, Department of Nuclear Medicine, Poliambulanza Foundation, 25124 Brescia, Italy

Edoardo Rosso, Department of General Surgery, Poliambulanza Foundation, 25124 Brescia, Italy

Author contributions: Aroldi F, Bertocchi P, Savelli G and Rosso E contributed equally to this work and wrote the paper; while Zaniboni A made critical revisions related to important intellectual content of the manuscript and approved the final version of the article.

Conflict-of-interest statement: The authors declare that they do not have any conflict of interest.

Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Correspondence to: Alberto Zaniboni, MD, Department of Medical Oncology, Poliambulanza Foundation, via Bissolati 57, 25124 Brescia, Italy. zanib@numerica.it

Telephone: +39-30-3515553 Fax: +39-30-3518270

Received: March 26, 2016
Peer-review started: March 27, 2016
First decision: May 17, 2016
Revised: June 7, 2016
Accepted: July 14, 2016
Article in press: July 18, 2016
Published online: September 15, 2016

Core Tip

Core tip: Pancreatic cancer is an emerging disease. In this review a possible therapeutic algorithm for second line treatment is hypothesized.